Register for free
Recent Quotes
My Watchlist
Indicators
Business Insurance Index
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Cibus, Inc. - Class A Common Stock (NQ:CBUS)

1.610 -0.040 (-2.42%)
Streaming Delayed Price Updated: 4:00 PM EDT, Jul 25, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Cibus, Inc. - Class A Common Stock

< Previous 1 2 3 4 5 Next >
Cibus to Participate in Upcoming August Investor Events
From Cibus US LLC
Via GlobeNewswire
CBUS Stock Earnings: Cibus Misses EPS, Beats Revenue for Q2 2024
CBUS stock results show that Cibus missed analyst estimates for earnings per share but beat on revenue for the second quarter of 2024. 
Via InvestorPlace
Cibus Reports Second Quarter Financial Results and Provides First Half Business Update
From Cibus US LLC
Via GlobeNewswire
Cibus Achieves Positive Initial Field Trial Results for Stacked Gene Edited Herbicide Tolerant Traits in Rice
From Cibus US LLC
Via GlobeNewswire
Cibus to Report Second Quarter 2024 Financial Results on August 8, 2024 After the Market Close and Host Conference Call
From Cibus US LLC
Via GlobeNewswire
Cibus Expands its Intellectual Property Coverage for Plant Gene Editing and Traits
From Cibus US LLC
Via GlobeNewswire
EXCLUSIVE: Cibus Expands Intellectual Property Coverage For 10 Plant Gene Editing And Trait Families
Cibus expands intellectual property coverage for ten gene editing and trait families. The patents cover areas including gene editing, productivity traits, and high-fiber wheat, strengthening the... 
Via Benzinga
Topics Intellectual Property
Cibus' Confirms Important Milestone for Nutrient Use Efficiency Trait Development
From Cibus US LLC
Via GlobeNewswire
Cibus Announces $13.0 Million Registered Direct Offering
From Cibus US LLC
Via GlobeNewswire
CIBUS ALERT: Bragar Eagel & Squire, P.C. is Investigating Cibus, Inc. on Behalf of Cibus Stockholders and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of Cibus, Inc. (CBUS) on Behalf of Investors
From Glancy Prongay & Murray LLP
Via Business Wire
Cibus to Participate in Upcoming June Investor Events
From Cibus US LLC
Via GlobeNewswire
INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation of Cibus, Inc. (CBUS) on Behalf of Investors
From Law Offices of Howard G. Smith
Via Business Wire
The Law Offices of Frank R. Cruz Announces Investigation of Cibus, Inc. (CBUS) on Behalf of Investors
From The Law Offices of Frank R. Cruz
Via Business Wire
Why Core & Main Shares Are Trading Lower By 11%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
 
Via Benzinga
Cibus’ White Mold (Sclerotinia) Resistance Trait Program Confirms Important Milestone for Next Generation Gene Edits in Canola
From Cibus US LLC
Via GlobeNewswire
Canada Added to a Growing List of Countries Regulating Cibus’ Gene Editing Technologies Similar to Conventional Breeding
Cibus Applauds the Canadian Food Inspection Agency’s (CFIA) New Guidelines for Plants Developed Using Gene Editing 
From Cibus US LLC
Via GlobeNewswire
Cibus to Participate in the BMO Global Farm to Market Conference
From Cibus US LLC
Via GlobeNewswire
CBUS Stock Earnings: Cibus Misses EPS, Beats Revenue for Q1 2024
CBUS stock results show that Cibus missed analyst estimates for earnings per share but beat on revenue for the first quarter of 2024. 
Via InvestorPlace
Cibus Reports First Quarter Financial Results and Provides Business Update
From Cibus US LLC
Via GlobeNewswire
Cibus to Report First Quarter 2024 Financial Results on May 9, 2024 and Host Conference Call
From Cibus US LLC
Via GlobeNewswire
CBUS Stock Earnings: Cibus Beats EPS, Beats Revenue for Q4 2023
CBUS stock results show that Cibus beat analyst estimates for earnings per share and beat on revenue for the fourth quarter of 2023. 
Via InvestorPlace
Cibus Reports Fourth Quarter Financial Results and Provides Business Update
From Cibus US LLC
Via GlobeNewswire
Earnings Scheduled For March 21, 2024
Companies Reporting Before The Bell • Creative Realities (NASDAQ:CREX) is expected to report quarterly earnings at $0.02 per share on revenue of $16.47 million. 
Via Benzinga
Cibus Named to Fast Company’s Annual List of the World’s Most Innovative Companies of 2024
Agricultural biotechnology company joins the ranks of Nvidia, YouTube, Taco Bell, and more 
From Cibus US LLC
Via GlobeNewswire
Cibus to Participate in the 36th Annual Roth Conference
From Cibus US LLC
Via GlobeNewswire
Cibus to Report Fourth Quarter 2023 Financial Results on March 21, 2024 and Host Conference Call
From Cibus US LLC
Via GlobeNewswire
Cibus and Loveland Products Collaborate to Develop and Sell Rice Traits in the US
From Cibus US LLC
Via GlobeNewswire
European Parliament Votes to Support Proposal for the Regulation of New Genomic Techniques
From Cibus US LLC
Via GlobeNewswire
European Parliament’s Environment Committee Votes to Support New Proposal for the Regulation of New Genomic Techniques
From Cibus US LLC
Via GlobeNewswire
< Previous 1 2 3 4 5 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.

Business Insurance is a singular, authoritative news and information source for executives focused upon risk management, risk transfer and risk financing.

Never miss important news. Subscribe to our newsletter.
Register for free

Information

Copyright 2024. BUSINESS INSURANCE HOLDINGS